Delivery Order SPE2DB22D3301-SPE2DB24FY1UC
Award Date
3/1/24
Potential Completion Date
3/22/24
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,609,982 units of the pharmaceutical product XEOMIN 100 Unit Vials. The contract has a potential value of $7,715.88 and a completion date of March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designation. Amerisourcebergen Drug Corp also...
The U.S. Defense Logistics Agency (DLA) has awarded a $40,462.00 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,020,471 XEOMIN 100 unit vials. This delivery order falls under a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
The U.S. Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $6,290.88 firm fixed price delivery order for 4,563,609,979 units of XEOMIN 100 unit vials. This award is part of an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $2,621.20, is for the provision of 4,563,451,765 units of the pharmaceutical product XEOMIN 100 UNIT VIALS. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,271,898 units of the pharmaceutical product XEOMIN 100 UNIT VIALS. The potential value of this contract is $7,863.60 and the period of performance extends through January 29, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is a prime contractor that provides pharmaceutical products and...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order worth $2,096.96 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,459,423 units of XEOMIN 100 unit vials with a completion date of February 16, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025,...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,301,682 units of the pharmaceutical product XEOMIN 100 UNIT VIALS. The $6,667.40 contract has a completion date of February 1, 2024. Amerisourcebergen Drug Corp is a for-profit organization that serves as a prime contractor to the DLA, providing a range of pharmaceutical products and medical supplies to support military...
The Defense Logistics Agency (DLA) awarded a $40,004.40 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,657,192 units of XEOMIN 100 unit vials. This delivery order falls under an indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,240,411 units of the drug XEOMIN 100 UNIT VIALS. The $5,242.40 contract has a performance period through May 1, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp, as the prime contractor, is the sole awardee on this delivery order, which is issued under a larger...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order valued at $6,553.00 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,563,609,981 units of XEOMIN 100 unit vials. This delivery order is issued under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with DLA, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC allows...